Related references
Note: Only part of the references are listed.Analysis of GNAQ mutations, proliferation and MAPK pathway activation in uveal melanomas
Helena Populo et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
Enzastaurin induces H2AX phosphorylation to regulate apoptosis via MAPK signalling in malignant glioma cells
Esther P. Jane et al.
EUROPEAN JOURNAL OF CANCER (2010)
Protein Kinase Cβ Is an Effective Target for Chemoprevention of Colon Cancer
Alan P. Fields et al.
CANCER RESEARCH (2009)
Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways
Hiroshi Matsuoka et al.
EXPERIMENTAL CELL RESEARCH (2009)
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Catherine D. Van Raamsdonk et al.
NATURE (2009)
Combination of Enzastaurin and Pemetrexed Inhibits Cell Growth and Induces Apoptosis of Chemoresistant Ovarian Cancer Cells Regulating Extracellular Signal-Regulated Kinase 1/2 Phosphorylation
Karen Braeutigam et al.
TRANSLATIONAL ONCOLOGY (2009)
Growth-Inhibitory and Antiangiogenic Activity of the MEK Inhibitor PD0325901 in Malignant Melanoma with or without BRAF Mutations
Ludovica Ciuffreda et al.
NEOPLASIA (2009)
Molecular pathways involved in the synergistic interaction of the PKCβ inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells
C. Tekle et al.
BRITISH JOURNAL OF CANCER (2008)
The heat shock protein antagonist 17-AAG potentiates the activity of enzastaurin against malignant human glioma cells
Esther P. Jane et al.
CANCER LETTERS (2008)
Enzastaurin, a protein kinase Cβ inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer
Keun-Wook Lee et al.
CANCER RESEARCH (2008)
Involvement of protein kinase C beta-extracellular signal-regulating kinase(1/2)/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion
Kun Guo et al.
CANCER SCIENCE (2008)
Targeted therapy for uveal melanoma
Pierre L. Triozzi et al.
CANCER TREATMENT REVIEWS (2008)
Molecular pathways mediating liver metastasis in patients with uveal melanoma
Silvin Bakalian et al.
CLINICAL CANCER RESEARCH (2008)
Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL
Johannes Rieger et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase Cβ inhibitor, in non-small cell lung cancer cells
Floriana Morgillo et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Oncogenic Mutations in GNAQ Occur Early in Uveal Melanoma
Michael D. Onken et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Authenticating Cell Lines in Ophthalmic Research Laboratories
Robert Folberg et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Enzastaurin, a protein kinase cβ -: Selective inhibitor, and its potential application as an anticancer agent in lung cancer
Roy S. Herbst et al.
CLINICAL CANCER RESEARCH (2007)
Inhibition of CDK4 impairs proliferation of pancreatic cancer cells and sensitizes towards TRAIL-induced apoptosis via downregulation of survivin
Michaela Retzer-Lidl et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Classical PKC isoforms in cancer
Georg Martiny-Baron et al.
PHARMACOLOGICAL RESEARCH (2007)
Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in vitro soft-agar cloning experiments
Axel-Rainer Hanauske et al.
INVESTIGATIONAL NEW DRUGS (2007)
Phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory diffuse large B-cell lymphoma
Michael J. Robertson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Targeting PKC in multiple myeloma: in vitro and in vivo effects of the novel, orally available small-molecule inhibitor enzastaurin (LY317615.HCl)
Klaus Podar et al.
BLOOD (2007)
Enzastaurin (LY317615), a protein kinase Cβ inhibitor, inhibits the AKT pathway and induces apoptosis in multiple myeloma cell lines
Mujahid A. Rizvi et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin
P Dasgupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Protein kinase C (PKC) family in cancer progression
J Koivunen et al.
CANCER LETTERS (2006)
Cell signalling diversity of the Gqα family of heterotrimeric G proteins
KB Hubbard et al.
CELLULAR SIGNALLING (2006)
Protein kinase C (PKC)-delta/-epsilon mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin
S Greco et al.
JOURNAL OF ENDOCRINOLOGY (2006)
The protein kinase Cβ-selective inhibitor, enzastaurin (LY317615.HCI), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer and glioblastoma xenografts
JR Graff et al.
CANCER RESEARCH (2005)
Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS
W Zuidervaart et al.
BRITISH JOURNAL OF CANCER (2005)
Involvement of the ERK signaling cascade in protein kinase C-mediated cell cycle arrest in intestinal epithelial cells
JA Clark et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regional treatment options for patients with ocular melanoma metastatic to the liver
ED Feldman et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice
KA Keyes et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
The past decade of experience with isolated hepatic perfusion
A Grover et al.
ONCOLOGIST (2004)
Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway
A Calipel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Acyclic N-(azacycloalkyl)bisindolylmaleimides:: Isozyme selective inhibitors of PKCβ
MM Faul et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Rapamycin-induced G(1) arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin
T Decker et al.
BLOOD (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Targeting protein kinase C: New therapeutic opportunities against high-grade malignant gliomas?
AB da Rocha et al.
ONCOLOGIST (2002)
Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: Molecular characterization of the involved signaling pathway
K Breitschopf et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
